Tag: johnson johnson

johnson johnson

Latest News

Yuhan Corporation CEO Cho Wook-je speaks during a press conference held in western Seoul on Friday. [YONHAP]

Yuhan eyes next Leclaza with R&D, open innovation after U.S. approval

Following the U.S. approval of lung treatment Leclaza, Korea’s first cancer drug to achieve the milestone, Yuhan Corporation is now seeking the next breakthrough with a renewed focus on research and development (R&D).

2024.8.23

LegoChem Biosciences' headquarters in Daejeon [LEGOCHEM BIOSCIENCES]

LegoChem strikes historic $1.7B license deal with Janssen

Korean biopharmaceutical firm LegoChem Biosciences signed a $1.7 licensing deal with Janssen Biotech for its solid cancer treatment candidate, LCB84, which targets colorectal and gastric cancer tumors.

2023.12.26

Celltrion reaches patent agreement for Stelara biosimilar CT-P43

Celltrion reached a patent agreement for its copycat drug of Stelara, a blockbuster psoriasis treatment by Janssen Pharmaceuticals, with Janssen’s parent company Johnson & Johnson (J&J).

2023.8.25

Tag: johnson johnson

johnson johnson

Latest News

Yuhan eyes next Leclaza with R&D, open innovation after U.S. approval

LegoChem strikes historic $1.7B license deal with Janssen

Most popular

Veteran actors Yoo Hae-jin, Ryu Seung-ryong win Baeksang Grand Prizes — as it happened

BTS comeback: Bright lights and drone shows light up the sky as 'Arirang' finally arrives — as it happened

179 dead after Jeju Air flight 7C2216 crashes at Muan International Airport — as it happened

Rooney, Maicon, Park Joo-ho score as Shield United wins Icons Match in Seoul — as it happened

Kim Soo-hyun addresses Kim Sae-ron relationship — as it happened

Celltrion reaches patent agreement for Stelara biosimilar CT-P43